Innovative strategies in healthcare are pushing the boundaries in infection prevention, with genome sequencing emerging as a leading tool in restricting the spread of staph bacteria in neonatal intensive care units (NICUs). Recently, researchers have leveraged genome sequencing to shed new light on the effectiveness of traditional infection prevention practices. One such study led by Dr. Sarah Hochman, Chief of Infectious Diseases at Tisch Hospital and Assistant Professor of Medicine at NYU Grossman School of Medicine, demonstrated that the use of antibiotic ointment and antiseptic wash can dramatically minimize staph transmission in NICUs.
This pioneering research underscores the value of Staphylococcus aureus screening coupled with targeted decolonization in stemming transmission. The study executed an in-depth analysis of 1,597 infants at Tisch Hospital’s NICU over approximately two years. Among the 188 infants identified as colonized with S. aureus, a notable 85.6% had methicillin-susceptible S. aureus (MSSA), and 14.4% were found with MRSA.
The study revealed that 20.7% of the infants colonized with S. aureus were implicated in at least one transmission incident, with these infants requiring a median stay of 96 days. The act of treating colonized infants with mupirocin, a topical antibiotic, coupled with a 2% chlorhexidine antiseptic wash lowered the transmission rate of S. aureus over 30 days to an impressive 0.6%, compared to 8.9% when no treatment was administered. The powerful granularity of genomic sequencing provided data-driven evidence that treatment of only 12 infants can halt one S. aureus transmission event.
The study also underscored the importance of weekly screenings in averting infection proliferation in the NICU environment. Dr. Hochman’s findings reinforce the efficacy of topical antibiotics in protecting patients across the age spectrum and not just infants. The team highlighted the reality that pathogens like S. aureus are often spread within medical settings via the environment and healthcare workers, but can be mitigated with the targeted use of topical decolonization treatments.
There’s no escaping the insidious nature of S. aureus within a medical setting with risks ranging from severe and life-threatening infections such as endocarditis, osteomyelitis, pneumonia, to sepsis and bloodstream infections. The deployment of genomic surveillance in hospitals allowed the research team to monitor pathogen transmission in real-time, offering a new stance in the fight against healthcare-associated infections. Not only does this intervention offer the potential to reduce infections and save costs, it also offered secondary benefits in the detection of antimicrobial resistance mechanisms and plasmids.
Ultimately, this research provides a potent testament to the innovative application of genomics, echoing the value of decolonisation techniques in preventing pathogen transmission.